Cargando…

Effect of chidamide on treating hepatosplenic T-cell lymphoma: A case report

BACKGROUND: Hepatosplenic T-cell lymphoma (HSTCL) is a rare subtype of non-Hodgkin’s lymphoma, which has an aggressive clinical course and an extremely poor prognosis. Chidamide is a novel, orally active, benzamide-type histone deacetylase (HDAC) inhibitor that has been used for peripheral T-cell ly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xing-Tong, Guo, Wei, Sun, Mo, Han, Wei, Du, Zhong-Hua, Wang, Xiu-Xiu, Du, Bei-Bei, Bai, Ou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385602/ https://www.ncbi.nlm.nih.gov/pubmed/32775395 http://dx.doi.org/10.12998/wjcc.v8.i14.3122

Ejemplares similares

Chidamide in the treatment of peripheral T-cell lymphoma
por: Chan, Thomas S, et al.
Publicado: (2017)

Simultaneous hepatosplenic T-cell lymphoma and myelofibrosis
por: Gabali, Ali M, et al.
Publicado: (2014)

Hepatosplenic T Cell Lymphoma: Diagnostic Conundrum
por: Chowdhury, Zachariah, et al.
Publicado: (2022)

Exploring the effect of chidamide on blastic plasmacytoid dendritic cell neoplasm: a case report and literature review
por: Wang, Shunan, et al.
Publicado: (2018)

Hemophagocytic lymphohistiocytosis associated with hepatosplenic T-cell lymphoma: case report
por: Paes, Vitor Ribeiro, et al.
Publicado: (2014)

Secondary skin involvement in gastric diffuse large B-cell lymphoma treated with chidamide: A case report
por: Yang, Dan, et al.
Publicado: (2018)

Hepatosplenic T-cell lymphoma with hepatocytotropism in a cat
por: Ii, Tatsuhito, et al.
Publicado: (2021)

Successful treatment with lenalidomide plus chidamide combination therapy in 3 heavily treated patients with non-Hodgkin lymphoma: Three cases report
por: Hu, Shaoxuan, et al.
Publicado: (2020)

Preclinical Evaluation of the HDAC Inhibitor Chidamide in Transformed Follicular Lymphoma
por: Zhong, Mengya, et al.
Publicado: (2021)

P1201: A REAL-WORLD STUDY OF CHIDAMIDE FOR PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA IN CHINA
por: Wang, Xin, et al.
Publicado: (2023)

Chidamide Maintenance Therapy Following Induction Therapy in Patients With Peripheral T-Cell Lymphoma Who Are Ineligible for Autologous Stem Cell Transplantation: Case Series From China
por: Guo, Wei, et al.
Publicado: (2022)

Four hepatosplenic T-cell lymphoma cases of Japanese patients
por: Kawai, Hidetsugu, et al.
Publicado: (2015)

Sinusoidal infiltration of hepatosplenic lymphoma in liver and bone marrow
por: Nigam, Neha, et al.
Publicado: (2017)

Hepatosplenic B-cell lymphoma associated with hemophagocytic syndrome: a case report.
por: Kwon, S. Y., et al.
Publicado: (1999)

Coexistent hairy cell leukaemia and hepatosplenic t-cell lymphoma: a case report
por: Gasljevic, Gorana, et al.
Publicado: (2014)

Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamide
por: Chen, Jinghong, et al.
Publicado: (2023)

Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
por: Shi, Yuankai, et al.
Publicado: (2017)

A case of hepatosplenic T-cell lymphoma successfully treated by HLA haploidentical stem cell transplantation
por: Iwaki, Noriko, et al.
Publicado: (2020)

Outcomes of allogeneic stem cell transplantation in hepatosplenic T-cell lymphoma
por: Rashidi, A, et al.
Publicado: (2015)

Intrasinusoidal pattern of bone marrow infiltration by hepatosplenic T‐cell lymphoma
por: Butler, Liesl Ann, et al.
Publicado: (2018)

Modified conditioning regimen with chidamide and high‐dose rituximab for triple‐hit lymphoma
por: Kang, Junnan, et al.
Publicado: (2021)

Macronodular hepatosplenic tuberculosis
por: Guidi, Roberto, et al.
Publicado: (2012)

Hepatosplenic T-Cell Lymphoma in an Immunocompetent Young Male: A Challenging Diagnosis
por: Ammad Ud Din, Mohammad, et al.
Publicado: (2020)

An integrated cytomorphology and sequencing analysis for hepatosplenic alpha/beta T‐cell lymphoma
por: Lu, Hsin‐Yu, et al.
Publicado: (2023)

Case Series of Hepatosplenic T-Cell Lymphoma: A Rare and Aggressive Disease
por: Tham, Yea Bing, et al.
Publicado: (2023)

Chidamide combined with traditional chemotherapy for primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma: A case report
por: He, Zhen-Dong, et al.
Publicado: (2022)

Sintilimab and Chidamide for Refractory Transformed Diffuse Large B Cell Lymphoma: A Case Report and A Literature Review
por: Chen, Chao, et al.
Publicado: (2021)

Chidamide triggers BTG1-mediated autophagy and reverses the chemotherapy resistance in the relapsed/refractory B-cell lymphoma
por: Xue, Kai, et al.
Publicado: (2021)

Hepatosplenic gamma delta T-cell lymphoma in a boy with visceral leishmaniasis: a case report
por: Mutreja, Deepti, et al.
Publicado: (2013)

A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China
por: Liu, Weiping, et al.
Publicado: (2021)

Comparison of Chemotherapy Combined With Chidamide Versus Chemotherapy in the Frontline Treatment for Peripheral T-Cell Lymphoma
por: Wang, Jinni, et al.
Publicado: (2022)

Novel HDAC inhibitor Chidamide synergizes with Rituximab to inhibit diffuse large B-cell lymphoma tumour growth by upregulating CD20
por: Guan, Xu-Wen, et al.
Publicado: (2020)

Single cell profiling of γδ hepatosplenic T-cell lymphoma unravels tumor cell heterogeneity associated with disease progression
por: Song, Wei, et al.
Publicado: (2022)

Hepatosplenic gamma-delta T-cell lymphoma in a female patient after delivery
por: Glaser, Marjana, et al.
Publicado: (2012)

Hepatosplenic Gamma/Delta T-Cell Lymphoma Masquerading as Alcoholic Hepatitis and Methadone Withdrawal
por: Morra, H.A. Lopez, et al.
Publicado: (2007)

Primary Hepatosplenic Large B-Cell Lymphoma: A Rare Aggressive Tumor
por: Morales-Polanco, M.R., et al.
Publicado: (2008)

Hepatosplenic T-Cell Lymphoma Diagnosed by Endoscopic Ultrasound-Guided Fine-Needle Biopsy
por: Shibata, Yoshiaki, et al.
Publicado: (2020)

Therapeutic effect of chidamide on relapsed refractory angioimmunoblastic T-cell lymphoma: A case report and literature review
por: Jin, Jingxia, et al.
Publicado: (2018)

Hepatosplenic Gamma Delta T-Cell Lymphoma (HSGDTCL): Two Rare Case Reports from Western India
por: Madabhavi, Irappa, et al.
Publicado: (2017)

Effective Treatment with PD-1 Antibody, Chidamide, Etoposide, and Thalidomide (PCET) for Relapsed/Refractory Natural Killer/T-Cell Lymphoma: A Report of Three Cases
por: Du, Lijun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gk26hs9nogihmt5rcfq9ea8eo6